---
title: "Cellectis to Report Second Quarter Financial Results on August 6, 2026"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/294414365.md"
description: "In New York on July 30, 2026, Cellectis, a leading clinical-stage biotech firm utilizing innovative gene-editing technology, disclosed plans to release its financial report for the second quarter of 2026 that concluded on June 30, 2026. The report will be made public on Thursday, August 6, 2026, following the closure of the US market. Cellectis is traded on Euronext Growth under the symbol ALCLS and on NASDAQ under the symbol CLLS."
datetime: "2026-07-30T20:32:30.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/294414365.md)
  - [en](https://longbridge.com/en/news/294414365.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/294414365.md)
generator: "portal-rs"
---

# Cellectis to Report Second Quarter Financial Results on August 6, 2026

In New York on July 30, 2026, Cellectis, a leading clinical-stage biotech firm utilizing innovative gene-editing technology, disclosed plans to release its financial report for the second quarter of 2026 that concluded on June 30, 2026. The report will be made public on Thursday, August 6, 2026, following the closure of the US market. Cellectis is traded on Euronext Growth under the symbol ALCLS and on NASDAQ under the symbol CLLS.

### Related Stocks

- [CLLS.US](https://longbridge.com/en/quote/CLLS.US.md)

## Related News & Research

- [PicS Q2 2026 Earnings Preview](https://longbridge.com/en/news/296709997.md)
- [REG - UIL Limited UIL Finance Ltd - Purchase of 2026 ZDP Shares](https://longbridge.com/en/news/296518280.md)
- [Xcel Energy sets BRL 0.26 per unit distribution for payment Oct. 26, 2026](https://longbridge.com/en/news/296646864.md)
- [Syn updates 2026 financial calendar for interim results release](https://longbridge.com/en/news/296331010.md)
- [Public Storage announces R$ 0.41 per unit dividend for Q3 2026](https://longbridge.com/en/news/296635332.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**